Categories: News

Telemedicine Platform Expands Business Opportunities for Sleep Physicians by Connecting Them to Patients across Their State, Removing Price and Logistical Barriers to Those Seeking Diagnosis and Treatment

For patients, the fully remote service offers new hope for Sleep Apnea sufferers across America, transitioning screening, testing and full lifecycle treatment from the clinic to the home

NEW YORK, NY / ACCESSWIRE / November 23, 2021 / Ognomy, the complete sleep apnea care platform, is now available to medical physicians across America. The startup, which was a finalist in Global Wellness Institute’s Innovation Awards and 43 North’s annual startup competition, is the only end-to-end virtual platform where sleep specialists can evaluate, diagnose, and treat patients all from the comfort of their homes. It’s a potentially life saving tool for the estimated 25 million Americans suffering from the pervasive sleep disorder. And for providers exploring business growth opportunities, Ognomy allows them to add telemedicine to their existing practice, eliminating the cost, time and logistical constraints of traditional brick and mortar care.

Benefits for physicians:

  • Direct integration with the platform makes it easy for physicians to expand their practice online, removing the logistical constraints of brick and mortar care
  • Ensures virtual, remote access and availability to patients anywhere, at any time
  • Improves schedule flexibility, support, logistics and efficiency for a practice whilst lowering costs
  • Providers are not limited by geography and can attract new patients throughout their state of licensure

About Ognomy

Ognomy is the vision of founder and CEO Daniel Rifkin, MD, a New York-based sleep medicine specialist. The start-up plans to quickly expand across America, and is already available in 11 states.

“Ognomy bridges the care gap for patients who are concerned for their health but are not comfortable visiting traditional sleep centers,” said Rifkin. Addressing the draw for providers, Rifkin added, “Sleep medicine professionals can extend their practice online with the infrastructure Ognomy offers. It is an incredible opportunity to support patients, spark business growth, and create a flexible work schedule that benefits everyone.”

About Sleep Apnea

Known as the “not-so-silent killer” due to its association with loud snoring, obstructive sleep apnea occurs when the muscles in the throat relax and close during sleep, which disrupts breathing. As a result, the body subconsciously wakes itself in an attempt to return breathing to normal, which can happen hundreds of times each night. Left untreated, the sleep disorder can lead to a wide range of health complications, including increased risk of heart attack, high blood pressure, type 2 diabetes, liver problems, and accidents due to drowsiness or lack of concentration.

Learn more at ognomy.com, watch this short video, or download Ognomy from the Apple App Store or Google Play.

Contact:

Judy Kelleher
Ognomy

Contact for enquiries:
Judy.kelleher@ognomy.com
Phone: 1-877-664-6669

Facebook: https://www.facebook.com/Ognomy
LinkedIn: https://www.linkedin.com/company/ognomyapp
Instagram: https://www.instagram.com/ognomyapp/
Twitter: https://twitter.com/ognomyapp

SOURCE: Ognomy

View source version on accesswire.com:
https://www.accesswire.com/674503/Telemedicine-Platform-Expands-Business-Opportunities-for-Sleep-Physicians-by-Connecting-Them-to-Patients-across-Their-State-Removing-Price-and-Logistical-Barriers-to-Those-Seeking-Diagnosis-and-Treatment

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

2 days ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

2 days ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

2 days ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago